Electromed Inc's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 69/208 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 36.00.In the medium term, the stock price is expected to trend up.The company has been performing well in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Electromed Inc's Score
Industry at a Glance
Industry Ranking
69 / 208
Overall Ranking
175 / 4578
Industry
Healthcare Equipment & Supplies
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Analyst Rating
Based on
4
analysts
Buy
Current Rating
36.000
Target Price
+27.89%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Electromed Inc Highlights
StrengthsRisks
Electromed, Inc. develops, manufactures, markets and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System, to patients with compromised pulmonary function. It applies High Frequency Chest Wall Oscillation (HFCWO) technologies in pulmonary care for patients of all ages. The SmartVest Clearway System consists of an inflatable therapy garment, a programmable air pulse generator and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall. The SmartVest Clearway is designed for comfort and convenience, so patients can readily fit therapy into their daily routines. The SmartVest System is primarily prescribed for patients with bronchiectasis, cystic fibrosis, and neuromuscular conditions such as cerebral palsy and amyotrophic lateral sclerosis. It also markets the Single Patient Use (SPU) SmartVest and SmartVest Wrap to health care providers in the acute care setting.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 33.15% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 64.00M.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 64.00M.
Fairly Valued
The company’s latest PE is 28.50, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 4.36M shares, decreasing 0.04% quarter-over-quarter.
Electromed, Inc. develops, manufactures, markets and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System, to patients with compromised pulmonary function. It applies High Frequency Chest Wall Oscillation (HFCWO) technologies in pulmonary care for patients of all ages. The SmartVest Clearway System consists of an inflatable therapy garment, a programmable air pulse generator and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall. The SmartVest Clearway is designed for comfort and convenience, so patients can readily fit therapy into their daily routines. The SmartVest System is primarily prescribed for patients with bronchiectasis, cystic fibrosis, and neuromuscular conditions such as cerebral palsy and amyotrophic lateral sclerosis. It also markets the Single Patient Use (SPU) SmartVest and SmartVest Wrap to health care providers in the acute care setting.
Ticker SymbolELMD
CompanyElectromed Inc
CEOCunniff (James L)
Websitehttps://smartvest.com/
FAQs
What is the current price of Electromed Inc (ELMD)?
The current price of Electromed Inc (ELMD) is 27.660.
What is the symbol of Electromed Inc?
The ticker symbol of Electromed Inc is ELMD.
What is the 52-week high of Electromed Inc?
The 52-week high of Electromed Inc is 35.560.
What is the 52-week low of Electromed Inc?
The 52-week low of Electromed Inc is 17.730.
What is the market capitalization of Electromed Inc?
The market capitalization of Electromed Inc is 231.15M.
What is the net income of Electromed Inc?
The net income of Electromed Inc is 7.54M.
Is Electromed Inc (ELMD) currently rated as Buy, Hold, or Sell?
According to analysts, Electromed Inc (ELMD) has an overall rating of Buy, with a price target of 36.000.
What is the Earnings Per Share (EPS TTM) of Electromed Inc (ELMD)?
The Earnings Per Share (EPS TTM) of Electromed Inc (ELMD) is 0.976.